Commercialization of novel Diagnostic Platform with Synaptic adaptation Arc trea...
Commercialization of novel Diagnostic Platform with Synaptic adaptation Arc treatment method for tinnitus patients.
Meeting demand for the first medical device for diagnosis and therapy of tinnitus is set to be a crucial challenge for future audiology and neurology. For that reason Kinetic Center of Advanced Audiology (www.kinetic-cna.pl/) aims...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
LISTEN
Liaison in Scientific Training for European auditory Neurosc...
3M€
Cerrado
READIHEAR
Rehabilitation and Diagnosis of Hearing Loss based on Electr...
2M€
Cerrado
EarDiTech
Precision Hearing Diagnostics and Augmented-hearing Technolo...
2M€
Cerrado
CochSyn
A diagnostic test for cochlear synaptopathy in humans
150K€
Cerrado
SAF2016-78898-C2-1-R
UNA COMBINACION DE ESTIMULACION TRANSCRANEAL Y OTOPROTECCION...
121K€
Cerrado
SAF2016-78898-C2-2-R
UNA COMBINACION DE ESTIMULACION TRANSCRANEAL Y OTOPROTECCION...
85K€
Cerrado
Información proyecto Tinnitus Platform
Duración del proyecto: 4 meses
Fecha Inicio: 2017-01-29
Fecha Fin: 2017-05-31
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Meeting demand for the first medical device for diagnosis and therapy of tinnitus is set to be a crucial challenge for future audiology and neurology. For that reason Kinetic Center of Advanced Audiology (www.kinetic-cna.pl/) aims to commercialize technologies for the Tinnitus examination and treatment. To do so, co-founders rely on their extensive experience and the interdisciplinary team of: audiologists, laryngologists, medical technicians, neurobiologists, neuroscientists, musical trainers, hearing care professionals, clinicians and nutritionists.
Our main objective today is to bring to the global market a novel Tinnitus Diagnostic Platform which is a IT platform of multiple test, that can give more information and indicate with more precision the nature of the tinnitus and Synaptic adaptation Arc therapy which is dedicated for tinnitus patients after sudden hearing loss. We have conducted preliminary research studies on a small group of around 200 patients and the promising results encouraged us to demonstrate clinical effectiveness of our solution on n a bigger number of subjects.
The key market application of Tinnitus Diagnostic Platform is to differentiate the pathology of hearing and finally to select appropriate treatment. Synaptic adaptation Arc therapy is based on continuous acoustic stimulation which enforces activity of hear cells and nervous system and gives opportunity to release Arc/Arg 3.1 protein that rebuild synapses. The project addresses the problem of lack of medical device for tinnitus diagnosis and very poor research on the course of the condition.
Finally, to fully exploit and to commercialize this new and EU-based technology, we want to open new Advanced Audiology Clinics around Europe to propose complex methods on hearing pathologies. The Future growth will be driven through sales of Tinnitus Diagnostic Platform to other Audiology Clinics (B2B) and sales of Synaptic adaptation Arc therapy treatment set to patients (B2C).